Literature DB >> 21168331

The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.

Soledad Bollo1, Luis J Núñez-Vergara, Sunhee Kang, Liang Zhang, Helena I Boshoff, Clifton E Barry, Juan A Squella, Cynthia S Dowd.   

Abstract

Nitroimidazole PA-824 is part of an exciting new class of compounds currently undergoing clinical evaluation as novel TB therapeutics. The recently elucidated mechanism of action of PA-824 involves reduction of the nitroimidazole ring and subsequent nitric oxide release. The importance of this compound and its unique activity prompted us to explore how substitution of the nitroimidazole ring would affect electrochemical reduction and antitubercular activity. We prepared analogs of PA-824 with bromo, chloro, cyano, and amino substituents in the 5-position of the aromatic ring. We found that substitution of the imidazole ring greatly influences reduction and the stability of the corresponding nitro radical anion. Further, the antitubercular activities of the bromo and chloro analogs may indicate that an alternate nitroreductase pathway within Mycobacterium tuberculosis exists. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168331      PMCID: PMC3021465          DOI: 10.1016/j.bmcl.2010.11.093

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.

Authors:  C K Stover; P Warrener; D R VanDevanter; D R Sherman; T M Arain; M H Langhorne; S W Anderson; J A Towell; Y Yuan; D N McMurray; B N Kreiswirth; C E Barry; W R Baker
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

2.  Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.

Authors:  Ujjini H Manjunatha; Helena Boshoff; Cynthia S Dowd; Liang Zhang; Thomas J Albert; Jason E Norton; Lacy Daniels; Thomas Dick; Siew Siew Pang; Clifton E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

3.  Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.

Authors:  Sandeep Tyagi; E Nuermberger; T Yoshimatsu; K Williams; I Rosenthal; N Lounis; W Bishai; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.

Authors:  Anne J Lenaerts; Veronica Gruppo; Karen S Marietta; Christine M Johnson; Diane K Driscoll; Nicholas M Tompkins; Jerry D Rose; Robert C Reynolds; Ian M Orme
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.

Authors:  Julian G Hurdle; Robin B Lee; Nageshwar R Budha; Elizabeth I Carson; Jianjun Qi; Michael S Scherman; Sang Hyun Cho; Michael R McNeil; Anne J Lenaerts; Scott G Franzblau; Bernd Meibohm; Richard E Lee
Journal:  J Antimicrob Chemother       Date:  2008-08-07       Impact factor: 5.790

6.  Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships.

Authors:  Pilho Kim; Sunhee Kang; Helena I Boshoff; Jan Jiricek; Margaret Collins; Ramandeep Singh; Ujjini H Manjunatha; Pornwaratt Niyomrattanakit; Liang Zhang; Michael Goodwin; Thomas Dick; Thomas H Keller; Cynthia S Dowd; Clifton E Barry
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

7.  Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.

Authors:  Pilho Kim; Liang Zhang; Ujjini H Manjunatha; Ramandeep Singh; Sejal Patel; Jan Jiricek; Thomas H Keller; Helena I Boshoff; Clifton E Barry; Cynthia S Dowd
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

8.  PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.

Authors:  Ramandeep Singh; Ujjini Manjunatha; Helena I M Boshoff; Young Hwan Ha; Pornwaratt Niyomrattanakit; Richard Ledwidge; Cynthia S Dowd; Ill Young Lee; Pilho Kim; Liang Zhang; Sunhee Kang; Thomas H Keller; Jan Jiricek; Clifton E Barry
Journal:  Science       Date:  2008-11-28       Impact factor: 63.714

  8 in total
  4 in total

1.  Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids.

Authors:  Hyungjin Eoh; Kyu Y Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

Review 2.  Nitroimidazoles for the treatment of TB: past, present and future.

Authors:  Tathagata Mukherjee; Helena Boshoff
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

Review 3.  Nitroaromatic Antibiotics as Nitrogen Oxide Sources.

Authors:  Allison M Rice; Yueming Long; S Bruce King
Journal:  Biomolecules       Date:  2021-02-12

Review 4.  Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases.

Authors:  Hollis D Showalter
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.